Sprouting of dopaminergic axons after striatal injury: confirmation by markers not dependent on dopamine metabolism.
Striatal injury increases dopamine metabolism in the nigrostriatal system but it is unclear whether this response is due to increased synthesis and activation of tyrosine hydroxylase within existing dopamine terminals and/or branching and sprouting of new terminals. While monitoring the density of tyrosine hydroxylase immunoreactive fibers suggests that sprouting occurs, this technique alone cannot adequately answer this question since the intensity of staining and thus the visibility of individual fibers are intimately linked to dopaminergic activity. However, by examining axons and their branches using markers that are independent of dopamine metabolism it is possible to determine whether dopaminergic sprouting does in fact take place. One month after using a Scouten wire knife to create a small lesion in the left striatum of normal C57/bl-6 mice, silver staining revealed an increase in the total number of neuronal fibers throughout the injured striatum. This was accompanied by intense staining of tyrosine hydroxylase-positive fibers around the wound and an increased density of striatal fibers labeled with dextran-biotin after injection of this neuronal tracer into the substantia nigra 1 month after striatal surgery and 5 days prior to sacrifice. The increase in tyrosine hydroxylase immunoreactivity confirms previous observations of increased dopaminergic activity after striatal injury. The increases in silver staining and dextran-biotin transport provide independent evidence that this increase in dopaminergic activity occurs because of sprouting of new fibers originating in the substantia nigra.
Liberatore
G T
GT
Department of Medicine, Austin & Repatriation Medical Centre, Heidelberg, Victoria, 3084, Australia.
Finkelstein
D I
DI
Wong
J Y
JY
Horne
M K
MK
Porritt
M J
MJ
Donnan
G A
GA
Howells
D W
DW
D000818:Animals; D001370:Axonal Transport; D001369:Axons / Q000473:pathology / Q000502:physiology*; D015415:Biomarkers; D001930:Brain Injuries / Q000473:pathology / Q000503:physiopathology*; D003342:Corpus Striatum / Q000293:injuries / Q000473:pathology / Q000503:physiopathology*; D004298:Dopamine / Q000378:metabolism*; D005456:Fluorescent Dyes; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009411:Nerve Endings / Q000473:pathology / Q000502:physiology; D009412:Nerve Fibers / Q000473:pathology / Q000502:physiology; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis
D015415:Biomarkers; D005456:Fluorescent Dyes; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine